Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

Share Price is delayed by 15 minutes
Get Live Data
872.00    -20.00 (-2.24%)
Bid:
870.00
Ask:
884.00
Spread: 14.00 (1.609%)
Market Cap: £18.51b
AIBG Live PriceLast checked at - London Stock Exchange

Intraday Aib Group Share Chart

Stabilisation Notice

23 Sep 2020 10:28

RNS Number : 8753Z
Morgan Stanley & Co. Int'l plc
23 September 2020
 

 

23 September 2020

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

AIB Group plc

Pre-stabilisation Period Announcement

Morgan Stanley & Co. International plc (contact: Morgan Stanley Debt Syndicate - Daniel Shane; telephone: +442076777070) hereby gives notice, as Coordinating Stabilisation Manager, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014.

 

Securities

Issuer:

AIB Group plc

Guarantor (if any):

N/A

Aggregate nominal amount:

EUR [TBD]

Description:

EUR [•] Callable Resettable Subordinated Notes due 2031, Callable 2026

Offer price:

[TBD]

Stabilisation

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

Citigroup Global Markets Limited

HSBC France

ING Bank N.V.

J&E Davy t/a Davy

 

J.P. Morgan Securities plc

Stabilisation period expected to start on:

23 September 2020

Stabilisation period expected to end no later than:

 30 October 2020

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable laws and rules.

Stabilisation trading venue:

Euronext Dublin, regulated market

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State or the United Kingdom (each, for the purposes of this provision, a "Relevant State") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Relevant State in accordance with Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Relevant State and notified to the competent authority in that Relevant State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Relevant State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Relevant State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STALJMLTMTBTMLM
Date   Source Headline
18th Apr 20197:00 amRNSAIB forms Joint Venture to acquire Payzone
1st Apr 20191:30 pmRNSDirectorate Changes
1st Apr 20197:03 amRNSAIB Group - Sale of Non Performing Loan Portfolio
28th Mar 201911:45 amRNSAIB Group plc Pillar 3 Report 2018
25th Mar 20197:00 amRNSNotice of Annual General Meeting
22nd Mar 20194:04 pmRNSAnnual Financial Report
22nd Mar 201910:30 amRNSDirectorate Change
18th Mar 20197:00 amRNSForm 8.3 - Findel plc
13th Mar 20197:00 amRNSDirectorate Changes
8th Mar 201910:30 amRNSNOTIFICATION OF TRANSACTION BY PDMR
8th Mar 20197:00 amRNSDirectorate Changes
1st Mar 20197:00 amRNSAnnual Financial Report
1st Mar 20197:00 amRNSAIB Group plc - Executive Management Change
27th Feb 20195:04 pmRNSDirectorate Changes
21st Feb 201910:00 amRNSNotification of Major Shareholding
18th Jan 201911:43 amRNSAIB Group plc 2019 Financial Calendar
7th Jan 201910:41 amRNSNotification of Major Holdings
14th Dec 20185:08 pmRNSDirectorate Change
2nd Nov 20185:32 pmRNSAIB EBA European Wide Stress Tests 2018
26th Oct 20187:02 amRNSTrading Statement
26th Oct 20187:00 amRNSDirectorate Change
19th Oct 20182:35 pmRNSAIB - Date for Q3 Trading Update
5th Sep 201812:45 pmRNSDirectorate Change
17th Aug 20184:24 pmRNSNOTIFICATION OF TRANSACTION BY PDMR
27th Jul 20187:00 amRNSHalf-year Report
18th Jul 201810:16 amRNSPost Stabilisation Notice - AIB
6th Jul 201812:02 pmRNSAIB_CBI Countercyclical Buffer Requirement
26th Jun 20189:31 amRNSPre Stab Notice - AIB EUR FXD 7y
31st May 20184:14 pmRNSAIB Group announces date for H1 Financial Results
17th May 20187:00 amRNSAIB - Sale of non performing loan portfolio
14th May 20187:00 amRNSAIB Group plc confirms MREL Requirement
25th Apr 20184:53 pmRNSResult of the Annual General Meeting
25th Apr 20187:00 amRNSAIB Q1 2018 Trading Statement
19th Apr 20184:52 pmRNSAIB statement on review of remuneration policy
18th Apr 20183:38 pmRNSAIB announces date for Trading Update
16th Apr 201812:39 pmRNSDirector/PDMR Shareholding
26th Mar 201810:02 amRNSPost Stabilisation Notice
22nd Mar 20181:20 pmRNSStabilisation Notice
22nd Mar 20187:00 amRNSNotice of AGM
1st Mar 20187:00 amRNSAnnual Financial Report
6th Feb 20189:22 amRNSRectification to previous PDMR Notification
14th Dec 20174:01 pmRNSDirectorate Change
13th Dec 201711:49 amRNSDirector/PDMR Shareholding
13th Dec 201711:02 amRNSCourt approval of the AIB reduction of capital
12th Dec 20174:39 pmRNSStandard Form TR-1
11th Dec 20177:02 amRNSAdmission to trading of AIB HoldCo Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.